Lakewood-Amedex Biotherapeutics Inc.
LABT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002079272
No open-market purchases or sales by Lakewood-Amedex Biotherapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $306.5K in total; no superinvestor holds it.
Holders of 5% or more of LABT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lakewood-Amedex Biotherapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| HPW Investments Holding Ltd. | 13G | 24.04%3.44M shares | New | Jun 23, 20261 filing | Jun 23, 2026 | SEC |
| Lindesfarne LLC | 13G | 9.88%203.4K shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
| WFI Equity, LLC | 13G | 8.80%1.26M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Lakewood-Amedex Biotherapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:15 PM ET | WFI Equity, LLC | 13G | 8.80%1.26M shares | New | May 13, 2026 | SEC |
| Aug 6, 20262:18 PM ET | Lindesfarne LLC | 13G | 9.88%203.4K shares | New | Apr 17, 2026 | SEC |
| Jun 23, 202611:10 AM ET | HPW Investments Holding Ltd. | 13G | 24.04%3.44M shares | New | Apr 23, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lakewood-Amedex Biotherapeutics Inc. shares.
No Form 144 notices for Lakewood-Amedex Biotherapeutics Inc. are on file.